Capecitabine plus irinotecan with or without apatinib for advanced colorectal cancer: an open label, controlled, prospective phase II trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2018
This article has no abstract
Epistemonikos ID: 613950a17c2f2771606c3736be465c7abe58fdf8
First added on: Apr 07, 2025